Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-23T03:08:18.507Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of prolonged-release bovine somatotropin for milk production in British Friesian dairy cows. 3. Effect on manufacturing properties and quality of Cheddar, Wensleydale and Cheshire cheese

Published online by Cambridge University Press:  27 March 2009

R. H. Phipps ,
V. Bines  and
F. Adriaens
R. H. Phipps
Affiliation:
AFRC Institute for Grassland and Animal Production, Church Lane, Shinfield, Reading RG2 9AQ, UK
V. Bines
Affiliation:
AFRC Institute of Food Research, Reading Laboratory, Shinfield, Reading RG2 9 AT, UK
F. Adriaens
Affiliation:
Monsanto plc, Monsanto House, Chineham Court, Chineham, Basingstoke RG24 OUL, UK
Get access Rights & Permissions [Opens in a new window]

Summary

Manufacturing properties and quality of Cheddar, Wensleydale and Cheshire cheeses made either with milk from cows treated with Sometribove, methionyl bovine somatotropin (BST), or with milk from untreated control cows were compared.

The source of milk did not affect manufacturing properties in terms of processing time. Renneting times for Cheddar cheese made from control milk and that made from milk produced by cows treated with BST were 57 and 55 min, respectively. Corresponding values for Wensleydale and Cheshire cheeses were 50 and 53 min and 49 and 46 min, respectively. The source of milk did not influence cheese composition in terms of moisture, fat, protein and salt. When cheeses were submitted to the National Grading Service, those made from milk produced by BST-treated cows were indistinguishable from those made from control milk. The total points scored (maximum 100) for Cheddar, Wensleydale and Cheshire cheeses made with milk from control and BST-treated cows were 89 and 88, 85 and 85, and 86 and 86, respectively.

Type
Animals
Information
The Journal of Agricultural Science , Volume 115 , Issue 1 , August 1990 , pp. 113 - 116
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Auberger, R., Lenior, J. & Remouf, F. (1988). L'incidence du traitement des vaches laitières par la somatotropine bovine sur la composition et les aptitudes technologiques du lait. Technique Laitière. No. 1030, 1–3.Google Scholar
Barbano, D. M. & Lynch, J. (1987). Milk from BSTtreated cows – its composition and manufacturing properties. In National Invitational Workshop on Bovine Somatotropin(Ed. Smith, R. D.) 09 21–23. Westport Plaza, St. Louis, USA. pp. 66–73. USDA: Washington DC.Google Scholar
Bitman, J., Wood, D. L., Tyrell, H. F., Bauman, D. E., Peel, C. J., Brown, A. C. G. & Reynolds, P. J. (1984). Blood and milk lipid responses induced by growth hormone administration to lactating cows. Journal of Dairy Science 67, 2873–2880.CrossRefGoogle ScholarPubMed
Chapman, H. R. & Harrison, A. J. W. (1963). Control of acid development in Cheddar cheese making. Journal of the Science of Dairy Technology 16, 139–144.CrossRefGoogle Scholar
Chilliard, Y. (1989). Long term effects of recombinant bovine somatotropin on dairy cow performance: a review. In Use of Somalolropin in Livestock Production (Eds Sejrsen, K., Vestergaard, M. & Neiman-Sorensen, A.). pp. 61–87. London: Elsevier Applied Science.Google Scholar
Desnouveaux, R., Montigny, H., Le Treut, J. H. & Schockmel, L. (1988). Verification de l'aptitude fromagère du lait de vaches traitées à la somatotropin bovine methionylée. Technique Lailière No. 1030, 4–7.Google Scholar
Eppard, P. J., Bauman, D. E., Bitman, J., Wood, D. L., Akers, R. M. & House, W. A. (1985). Effect of dose of bovine growth hormone on milk composition: alphalactalbumin, fatty acids and mineral elements. Journal of Dairy Science 68, 3047–3054.CrossRefGoogle ScholarPubMed
Marshall, R. T., & Cartledge, M. F. (1989). Sometribove (USAN), (recombinant methionyl bovine somatotropin) does not effect clotting time of milk. Cultured Dairy Products Journal 24, 8.Google Scholar
Phipps, R. H., Weller, R. F., Craven, N. & Peel, C. J. (1990). Use of prolonged-release bovine somatotropin for milk production in British Friesian dairy cows. I. Effect on intake, milk production and feed efficiency in two consecutive lactations of treatment. Journal of Agricultural Science, Cambridge 115, 95–104.CrossRefGoogle Scholar
Van Den Berg, G. (1989). Milk from BST treated cows, its quality and suitability for processing. In Use of Somatotropin in Livestock Production (Eds Sejrsen, K., Vestergaard, M. & Neiman-Sorensen, A.). pp. 178–191. London: Elsevier Applied Science.Google Scholar
Weller, R. F., Phipps, R. H., Craven, N. & Peel, C. J. (1990). Use of prolonged-release bovine somatotropin for milk production in British Friesian dairy cows. 2. Effect on health and reproduction in two consecutive lactations of treatment. Journal of Agricultural Science, Cambridge 115, 105–112.CrossRefGoogle Scholar